GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PEPTONIC medical AB (XSAT:PMED) » Definitions » Total Equity

PEPTONIC medical AB (XSAT:PMED) Total Equity : kr64.35 Mil (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is PEPTONIC medical AB Total Equity?

PEPTONIC medical AB's total equity for the quarter that ended in Mar. 2024 was kr64.35 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

PEPTONIC medical AB Total Equity Historical Data

The historical data trend for PEPTONIC medical AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PEPTONIC medical AB Total Equity Chart

PEPTONIC medical AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 85.71 117.82 53.12 47.09 75.32

PEPTONIC medical AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 82.74 84.13 76.49 75.32 64.35

PEPTONIC medical AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

PEPTONIC medical AB's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=106.736-31.413
=75.32

PEPTONIC medical AB's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=90.705-26.352
=64.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PEPTONIC medical AB Total Equity Related Terms

Thank you for viewing the detailed overview of PEPTONIC medical AB's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

PEPTONIC medical AB (XSAT:PMED) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PEPTONIC medical AB (XSAT:PMED) » Definitions » Total Equity
Comparable Companies
XSAT:ODI OSTO:VIVE XSAT:DICOT OSTO:ERMA OSTO:NANEXA OSTO:NEWBRY OSTO:KLAR OSTO:RLS OSTO:EMPLI OSTO:GABA ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
28L:Germany
Address
Gustavslundsvägen 143, Bromma, SWE, SE-167 51
Website
https://www.peptonicmedical.se
PEPTONIC medical AB is a pharmaceutical company. It is engaged in developing oxytocin-based products for the treatment of menopausal symptoms, such as vaginal atrophy and vaginal dryness. Oxytocin is for medical use and offers an alternative to estrogen and estrogen-like acting compounds for menopausal and postmenopausal women. The company is based in Sweden.

PEPTONIC medical AB (XSAT:PMED) Headlines

No Headlines